Brisbane Heat star Mark Steketee 'shattered' after Big Bash substitution
Mark Steketee couldn't hide his frustration after being subbed in the 10th over during the Heat's semi-final clash with the Scorchers. SOURCE: Fox Cricket
(Bloomberg) -- The U.S. and China are pursuing divergent economic policies in the aftermath of the coronavirus recession in a role reversal from last time the world economy was recovering from a shock.One of the takeaways from the annual National People’s Congress under way in Beijing is a conservative growth goal, with a tighter fiscal-deficit target and restrained monetary settings. That’s a big contrast with Washington, where President Joe Biden is preparing a second major fiscal package after he gets final approval for his $1.9 trillion stimulus.The widening policy divergence is putting strains on exchange rates and could potentially reshape global capital flows. It stems, in part, from different policy lessons from the 2007-09 crisis.A stunted and choppy U.S. recovery left key Democrats concluding it’s vital to “go big” on stimulus and keep it flowing. For monetary policy the moral was: “Don’t hold back” and “don’t stop until the job is done,” Federal Reserve Chair Jerome Powell said last week.China’s leaders have a different take. A massive unleashing of credit growth back then led to unused infrastructure, ghost towns, excess industrial capacity and an overhang of debt. While rapid containment of the pandemic meant the economy didn’t need as much help in 2020, President Xi Jinping and his team are now winding things back to re-focus on longer-term initiatives to strengthen the technology sector and tamp down debt risks.“Each learned a lesson from the previous episode, and so it is kind of a swap of positions,” said Nathan Sheets, head of global economic research at PGIM Fixed Income and a former U.S. Treasury undersecretary for international affairs. The policy mix now makes “a compelling case for renminbi appreciation,” Sheets said.That’s a view that’s widely shared: the median forecast in a Bloomberg survey is for a strengthening to 6.35 against the dollar by the end of the year, from 6.5114 in Shanghai late Tuesday.One of China’s financial regulators, Guo Shuqing, highlighted in a briefing just days before the opening of the annual legislative gathering that high leverage within the financial system must continue to be addressed. Guo pointed to worries about inflated property prices and the risk of overseas money pouring in to take advantage of the premiums China’s assets offer. He also indicated the nation’s lending rates will likely go up this year.What Bloomberg’s Economists Say...“China is increasingly shifting its attention from pandemic recovery to managing the economy in more normal conditions.”--Chang Shu, chief Asia economistFor the full report, click hereWhile U.S. Treasury yields have surged recently, 10-year rates remain less than half those in China, where the central bank has forsworn Western-style zero interest rates or quantitative easing.“Unlike many of its peers, including the Fed, China’s central bank has continued to calibrate its policy partially with a view to prevent an excessive rise in asset prices,” said Frederic Neumann, co-head of Asian economics research at HSBC Holdings Plc in Hong Kong. Confronted with currency-appreciation risks, China will be hoping for a “well-timed exit from the Fed’s ultra-ease stance.”That’s unlikely to come soon. Powell in three appearances the past fortnight has made clear the Fed is going to keep policy rates near zero until well into the economic recovery, when most jobless Americans are brought back into employment. He also gave no indication asset purchases will be tapered as Biden’s fiscal stimulus kicks in in coming months.As China contends with capital inflows, the U.S. is likely to be pumping out a greater supply of dollars into the global economy -- via a widening current-account deficit -- as its growth revs up, supercharged by Biden’s stimulus and the Fed’s easy stance.“There’s been a regime break,” in the U.S. with the outsize Biden relief bill and a planned longer-term follow-up, said Robin Brooks, chief economist at the Institute of International Finance. As growth soars past 6% this year, a wider current-account deficit will be “the pressure valve” given domestic production constraints, he said.Brooks projects that deficit will hit 4% of gross domestic product this year. That would be the highest since large shortfalls during the 2002-08 period, when a broad measure of the dollar tumbled as much as 27%.Read More: Dollar Is Increasingly Overvalued as Deficit Widens, IIF Says“As our fiscal support goes into uncharted territory, it puts enormous pressure on our budget deficits -- and by inference our domestic saving rate and the current account and trade deficit, with the consequences primarily falling on the currency,” said Stephen Roach, a Yale University senior fellow and former chairman of Morgan Stanley Asia.China’s reluctance toward the kind of “go big” message of Treasury Secretary Janet Yellen dates back many years. After unleashing a fiscal package of 4 trillion yuan ($586 billion, at the time) and an unprecedented surge in broader credit after the 2008 crisis, Beijing was already by 2012 saying it wouldn’t do that again.Reticence toward across-the-board stimulus later turned into a concerted push to rein in leverage. A May 2016 front-page treatise in the People’s Daily -- the Communist Party’s mouthpiece -- blasted excessive debt as the “original sin” sowing risks across financial and real-estate markets. The anonymous article -- widely said to have been written by Vice Premier Liu He, Xi’s top economic adviser -- called stimulating the economy through easy monetary policy a “fantasy.”So with the country’s success in applying draconian restrictions to contain the coronavirus, it should come as little surprise that Beijing is returning toward its pre-pandemic focus on building domestic tech capabilities and managing down debt risks.After ditching an annual growth target for 2020 given the turmoil caused by Covid-19, China’s leadership set a goal of a GDP increase of more than 6% this year -- conservative since it’s well below economists’ projections for this year’s expansion.In the meantime, surging American GDP gains are set to lift China’s prospects as well. Exports to the U.S. soared more than 87% in the first two months of this year compared with the pandemic-hit period a year before, faster than China’s overall rise of just under 61%.“The U.S. locomotive is back on track,” said Catherine Mann, global chief economist at Citigroup Inc.(Updates yuan forecast, trading in seventh paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Investing in any special purpose acquisition company, or SPAC, that hasn't yet identified a target to take public is essentially a bet on management. In this Fool Live video clip, recorded on March 1, Frankel and Industry Focus host Jason Moser discuss why the SPAC's sponsor Simon Property Group (NYSE: SPG) has a talent for allocating capital and could leverage its scale and expertise to deliver value for its shareholders. Jason Moser: OK well, let's talk about one that doesn't have anything in the hopper right now, but it sounds like they are on the hunt at least.
While Australia considers its vaccine passport options, one country has rolled out its official health certificate.
Q4 2020 net revenues of $217 million increased 12%, compared to Q4 2019Q4 2020 net loss of $44 million or $0.17 per diluted share, compared to a net loss of $28 million or $0.12 per diluted share in Q4 2019; Q4 2020 and Q4 2019 include losses on extinguishment of debt of $44 million and $30 million, respectivelyQ4 2020 Adjusted EBITDA of $113 million increased 20%, compared to Q4 2019Q4 2020 Adjusted EPS of $0.09 improved by $0.04 per diluted share, compared to Q4 2019December 31, 2020 total debt of $1,861 million, net debt of $1,797 million, and net leverage ratio reduced to 4.3xFull-year 2021 outlook revenue growth of 9% to 12% CLEVELAND, March 09, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2020. Fourth-quarter 2020 net revenues increased 12% to $217 million, compared with $193 million in the fourth-quarter a year ago. Net loss attributable to Sotera Health (“net loss”) was $44 million, or $0.17 per diluted share, compared with a net loss of $28 million, or $0.12 per diluted share in the fourth-quarter 2019. Fourth-quarter 2020 net loss included a $44 million charge related to the previously announced paydown of $1,111 million of debt with proceeds from the Company’s initial public offering, and fourth-quarter 2019 net loss included a $30 million charge related to the refinancing of debt. Adjusted EBITDA for the fourth-quarter 2020 increased by 20% to $113 million over the prior-year quarter. Fourth-quarter 2020 Adjusted earnings per diluted share (“Adjusted EPS”) was $0.09, an increase of $0.04 per diluted share, compared to the fourth-quarter 2019. Please refer to the section “Non-GAAP Financial Measures” provided later in this release. For full-year 2020, net revenues increased 5% to $818 million, compared with $778 million for 2019. Full-year 2020 net loss was $39 million, or $0.16 per diluted share, compared with a net loss of $21 million, or $0.09 per diluted share, for 2019. Full-year 2020 and 2019 net losses included the $44 million and $30 million charges referenced above. Full-year 2020 Adjusted EBITDA increased nearly 11% to $420 million, compared to 2019. Adjusted EPS was $0.42 in 2020, a decrease of 2% over 2019 as interest expense increased by approximately $58M for full-year 2020. Please refer to the section “Non-GAAP Financial Measures” provided later in this release. “Our fourth-quarter and full-year 2020 results demonstrate the resilience of our business model and ability of our company to perform in a rapidly shifting environment,” said Chairman and Chief Executive Officer, Michael B. Petras, Jr. “Our three businesses – Sterigenics, Nordion and Nelson Labs – successfully navigated a global pandemic, pivoting to meet increased demand for products and services critical to protecting against the coronavirus, while ensuring continuity and quality of service for our broad-spectrum of healthcare customers. Our focus has been, and continues to be, supporting our Sotera Health global team members, providing a healthy and safe work environment and additional support and flexibility as needed.” Petras continued, “Despite the external challenges, we delivered double-digit Adjusted EBITDA growth, expanded margins, continued to make necessary infrastructure enhancements, completed the acquisition of Iotron and executed a highly successful IPO. I am tremendously proud of, and grateful to, the entire Sotera Health team for their dedication and professionalism during this important time for the company. We look forward to building on our momentum as 2021 proceeds.” Fourth-Quarter and Full-Year 2020 Review by Business Segment Sterigenics For fourth-quarter 2020, net revenues from Sterigenics were $135 million, an increase of 11% compared to the fourth-quarter a year ago. Segment income was $74 million, an increase of more than 14%. For full-year 2020, Sterigenics net revenues were $499 million, an increase of 6% compared to 2019. Segment income increased 9% to $267 million. Revenue and segment income growth for both the fourth-quarter and full-year 2020 were driven by enhanced utilization of existing capacity, favorable pricing, and the acquisition of Iotron. Nordion For fourth-quarter 2020, net revenues from Nordion were $29 million, an increase of 18%, compared to the fourth-quarter a year ago. Segment income increased nearly 30% to $16 million. The increases in both revenue and segment income were driven by favorable pricing and harvest schedules for industrial-use Co-60, which often vary quarter to quarter. Segment income also benefited from favorable pricing and Co-60 mix. For full-year 2020, net revenues from Nordion were $115 million, a decline of 1% compared to 2019. The slight decline in sales for the year was driven by lower volumes of medical-use Co-60 impacted by COVID-19. Segment income increased by more than 7% to $67 million, driven by favorable pricing and Co-60 mix. Nelson Labs For fourth-quarter 2020, net revenues from Nelson Labs were $53 million, an increase of more than 11% compared to the fourth-quarter a year ago. Segment income increased more than 30% to $23 million. For full-year 2020, net revenues from Nelson Labs were $205 million, an increase of more than 7% compared to 2019. Segment income increased 19% to $86 million. Revenue and segment income growth for both the fourth-quarter and full-year 2020 were driven by increased demand for testing related to personal protective equipment, partially offset by a reduction in other lab testing volumes. Balance Sheet and Liquidity As of December 31, 2020, Sotera Health had $1,861 million in total debt, and $102 million in cash and cash equivalents, compared to $2,848 million in total debt and $63 million in cash and cash equivalents as of December 31, 2019. No material debt balances currently outstanding mature until 2026. Sotera Health’s net leverage ratio as of December 31, 2020 was 4.3x, compared to 7.5x at December 31, 2019. Please refer to the section “Non-GAAP Financial Measures” provided later in this release. Full-Year 2021 Outlook Today, Sotera Health is providing its full-year 2021 outlook: Net revenues in the range of $890 million to $920 million, representing growth of approximately 9% to 12%, compared to the prior year,Adjusted EBITDA in the range of $465 million to $485 million, representing growth of approximately 11% to 16%, compared to the prior year,Tax rate applicable to Adjusted Net Income of approximately 28%,Adjusted EPS in the range of $0.78 to $0.86,A fully diluted share count in the range of 281 million to 283 million shares on a weighted-average basis,Capital expenditures in the range of $100 million to $110 million, andNet leverage reduction of approximately ¾ of a turn. The guidance provided above contains a number of assumptions, including, among others, the company’s current expectations regarding the impact of the COVID-19 pandemic including the rate of recoveries of elective procedures and new product development testing, and that exchange rates remain constant for the full year 2021. The company does not provide a reconciliation of the forward-looking Adjusted EBITDA, Adjusted Net Income, and Adjusted EPS guidance to the most directly comparable GAAP measure, as this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain items, including, among others, uncertainties caused by the global COVID-19 pandemic, changes to the regulatory landscape, restructuring items and certain fair value measurements, all of which are potential adjustments for future earnings. The variability of these items could have a potentially unpredictable, and a potentially significant, impact on our future GAAP results. The guidance provided above is based on current plans and expectations and is subject to a number of known and unknown certainties and risks, including those set forth below under “Forward-Looking Statements.” Recent Accomplishments Closing of initial public offering in November 2020.Paydown of $1,111 million of debt and expansion of Revolving Credit Facility in November and December 2020, respectively.Successful repricing of First Lien Term Loan facility in January 2021. Upcoming Investor Events Barclays Global Healthcare Conference at 9:10 am Eastern, March 10, 2021.KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum at 9:15 am Eastern, March 23, 2021. Earnings WebcastSotera Health management will host a conference call and webcast to discuss the Company’s operating highlights and financial results at 9:00 a.m. Eastern today. To participate in the live call, please dial 1-833-303-1211 if dialing from within the United States and Canada or 1-918-922-6527 if dialing from other locations, using conference ID #1765289, at least 10 minutes prior to the scheduled start time. A live webcast of the conference call and accompanying materials also may be accessed via the Investor Relations section of the Company’s website at https://investors.soterahealth.com/. A replay of the webcast will be available beginning at 12 noon Eastern on March 9 for a period of one year. Forward-Looking Statements This release contains forward-looking statements that reflect management’s expectations about future events and the Company’s operating plans and performance and speak only as of the date hereof. You can identify these forward-looking statements by the use of forward-looking words such as “will,” “may,” “plan,” “estimate,” “project,” “believe,” “anticipate,” “expect,” “intend,” “should,” “would,” “could,” “target,” “goal,” “continue to,” “positioned to,” “are confident” or the negative version of those words or other comparable words. Any forward-looking statements contained in this release are based upon our historical performance and on our current plans, estimates and expectations in light of information currently available to us. The inclusion of this forward-looking information should not be regarded as a representation by us that the future plans, estimates or expectations contemplated by us will be achieved. These forward-looking statements are subject to various risks, uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity. These risks and uncertainties include, without limitation, any disruption in the availability or supply of ethylene oxide (EO) or Cobalt-60; changes in industry trends, environmental, health and safety regulations or preferences; the impact of current and future legal proceedings and liability claims, including litigation related to purported exposure to emissions of EO from our facilities in Illinois, Georgia and New Mexico and the possibility that other claims will be made in the future relating to these or other facilities; our ability to increase capacity at existing facilities, renew leases for our facilities and build new facilities in a timely and cost-effective manner; the risks of doing business internationally; and any inability to pursue strategic transactions or find suitable acquisition targets. For additional discussion of these risks and uncertainties, please refer to Company’s filings with the SEC, such as its annual and quarterly reports. We do not undertake any obligation to publicly update or revise these forward-looking statements, except as otherwise required by law. Non-GAAP Financial Measures To supplement our consolidated financial statements presented in accordance with GAAP, we consider Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Net Debt and Net Leverage Ratio, financial measures that are not based on any standardized methodology prescribed by GAAP. We define Adjusted Net Income as net income (loss) before amortization and certain other adjustments that we do not consider in our evaluation of our ongoing operating performance from period to period. We define Adjusted EBITDA as Adjusted Net Income before interest expense, depreciation (including depreciation of Co-60 used in our operations) and income tax provision applicable to Adjusted Net Income. Adjusted EBITDA Margin is equal to Adjusted EBITDA divided by net revenues. We define Adjusted EPS as Adjusted Net Income divided by the weighted average number of diluted shares outstanding. Our Net Debt is equal to our total debt, plus unamortized debt issuance costs and debt discounts, less cash and cash equivalents. Our Net Leverage Ratio is equal to Net Debt divided by Adjusted EBITDA. We use these non-GAAP financial measures as the principal measures of our operating performance. Management believes these are useful because they allow management to more effectively evaluate our operating performance and compare the results of our operations from period to period without the impact of certain non-cash items and non-routine items that we do not expect to continue at the same level in the future and other items that are not core to our operations. We believe that these measures are useful to our investors because they provide a more complete understanding of the factors and trends affecting our business than could be obtained absent this disclosure. In addition, we believe these measures will assist investors in making comparisons to our historical operating results and analyzing the underlying performance of our operations for the periods presented. Our management also uses these measurements in their financial analysis and operational decision-making and Adjusted EBITDA serves as the metric for attainment of our primary annual incentive program. These measures may be calculated differently from, and therefore may not be comparable to, a similarly titled measure used by other companies. About Sotera Health Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®. INVESTOR RELATIONS CONTACTS Sally J. Curley, IRCCurley Global IR, LLCIR@soterahealth.comJenny KobinIR Advisory SolutionsIR@soterahealth.com MEDIA CONTACT Kristin GibbsChief Marketing Officer, Sotera Healthkgibbs@soterahealth.com Source: Sotera Health Company Sotera Health CompanyConsolidated Statements of Operations (in thousands, except per share amounts)(unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019Revenues: Service$189,495 $171,162 $713,520 $673,037 Product27,350 22,323 104,638 105,290 Total net revenues216,845 193,485 818,158 778,327 Cost of revenues: Service85,973 84,884 333,359 333,290 Product10,295 11,380 41,227 49,606 Total cost of revenues96,268 96,264 374,586 382,896 Gross profit120,577 97,221 443,572 395,431 Operating expenses: Selling, general and administrative expenses53,156 37,120 178,525 147,480 Amortization of intangible assets15,040 14,620 59,029 58,562 Impairment of long-lived assets— 11 — 5,792 Total operating expenses68,196 51,751 237,554 211,834 Operating income52,381 45,470 206,018 183,597 Interest expense, net48,117 43,251 215,259 157,729 Loss on extinguishment of debt44,262 30,168 44,262 30,168 Foreign exchange loss (gain)140 (4,582) (5,230) 3,862 Other income, net(5,060) (2,500) (9,413) (7,246)Loss before income taxes(35,078) (20,867) (38,860) (916)Provision (benefit) for income taxes8,308 6,879 (1,369) 19,509 Net loss(43,386) (27,746) (37,491) (20,425)Less: Net income attributable to noncontrolling interests294 154 1,126 425 Net loss attributable to Sotera Health Company$(43,680) $(27,900) $(38,617) $(20,850) Loss per share: Basic and diluted$(0.17) $(0.12) $(0.16) $(0.09)Weighted average number of shares outstanding: Basic and diluted253,470 232,400 237,696 232,400 Sotera Health Company Segment Data(in thousands)(unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019Segment revenues: Sterigenics$134,819 $121,321 $498,773 $471,708 Nordion28,711 24,296 114,745 116,165 Nelson Labs53,315 47,868 204,640 190,454 Total net revenues$216,845 $193,485 $818,158 $778,327 Segment income: Sterigenics$73,836 $64,542 $266,639 $244,904 Nordion16,111 12,498 66,803 62,196 Nelson Labs23,115 17,435 86,417 72,832 Total segment income113,062 94,475 419,859 379,932 Less adjustments: Interest expense, net48,117 43,251 215,259 157,729 Depreciation and amortization(a)36,406 36,591 143,564 146,719 Impairment of long-lived assets and intangible assets(b)— 11 — 5,792 Share-based compensation(c)6,968 1,762 10,987 16,882 Capital restructuring bonuses(d)2,702 1,510 2,702 2,040 (Gain) loss on foreign currency and embedded derivatives(e)(3,663) (5,636) (8,454) 2,662 Acquisition and divestiture related charges, net(f)962 386 3,932 (318)Business optimization project expenses(g)40 2,710 2,524 4,195 Plant closure expenses(h)261 567 2,649 1,712 Loss on extinguishment of debt(i)44,262 30,168 44,262 30,168 Professional services relating to EO sterilization facilities(j)11,301 3,428 36,671 11,216 Accretion of asset retirement obligation(k)470 594 1,946 2,051 COVID-19 expenses(l)314 — 2,677 — Consolidated loss before income taxes$(35,078) $(20,867) $(38,860) $(916) (a)Includes depreciation of Co-60 held at gamma irradiation sites.(b) Represents impairment charges related to the decision to not reopen the Willowbrook, Illinois facility in September 2019.(c) Includes non-cash share-based compensation expense. 2019 also includes $10.0 million of one-time cash share-based compensation expense related to the pre-IPO Class C Units, which vested in the third quarter of 2019.(d) Represents cash bonuses for members of management relating to the November 2020 IPO and the December 2019 refinancing.(e) Represents the effects of (i) fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries’ functional currencies, and (ii) non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion.(f) Represents (i) certain direct and incremental costs related to the acquisitions of Gibraltar Laboratories, Inc. (“Nelson Fairfield”) in 2018 and Iotron Industries Canada, Inc. in July 2020, and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018.(g) Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects.(h) Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.(i) Represents expenses incurred in connection with the refinancing of our debt capital structure in December 2019 and paydown of debt following the November 2020 IPO, including accelerated amortization of prior debt issuance and discount costs, premiums paid in connection with early extinguishment and debt issuance and discount costs incurred for the new debt.(j) Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees.(k) Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.(l) Represents non-recurring costs associated with COVID-19 pandemic, including donations to related charitable causes and special bonuses for front-line personnel working on-site during lockdown periods. Sotera Health Company Condensed Consolidated Balance Sheets(in thousands)(unaudited) As of December 31, 2020 2019Assets Current assets: Cash and cash equivalents$102,454 $63,025 Accounts receivable, net91,735 88,644 Inventories, net34,093 37,396 Other current assets86,733 63,289 Total current assets315,015 252,354 Property, plant, and equipment, net609,814 581,954 Operating lease assets45,963 — Other intangible assets, net643,366 696,006 Goodwill1,115,936 1,035,865 Other assets31,185 14,495 Total assets$2,761,279 $2,580,674 Liabilities and equity Total current liabilities$140,598 $123,990 Long-term debt, less current portion1,824,789 2,800,873 Other noncurrent liabilities219,502 159,708 Deferred income taxes121,816 137,235 Total liabilities2,306,705 3,221,806 Total equity (deficit) 454,574 (641,132)Total liabilities and equity$2,761,279 $2,580,674 Sotera Health CompanyCondensed Consolidated Statements of Cash Flows(in thousands)(unaudited) Year Ended December 31, 2020 2019Operating activities: Net loss$(37,491) $(20,425)Non-cash items 169,869 177,817 Changes in operating assets and liabilities (11,793) (8,351)Net cash provided by operating activities 120,585 149,041 Investing activities: Purchases of property, plant and equipment (53,507) (57,257)Purchase of Iotron Industries Canada, Inc., net of cash acquired (105,187) — Net cash used in investing activities (158,694) (57,257)Financing activities: Proceeds from issuance of common stock, net of underwriting discounts and issuance costs 1,155,961 — Proceeds from revolving credit facility and long-term borrowings 150,000 3,144,600 Dividends and distributions to shareholders — (691,170)Repurchase of common shares (34,000) — Payments of debt issuance costs and prepayment premium (19,746) (17,034)Payments on revolving credit facility and long-term borrowings (1,177,325) (2,561,084)Other (1,458) (1,342)Net cash provided by (used in) financing activities 73,432 (126,030)Effect of exchange rate changes on cash and cash equivalents 4,106 485 Net increase (decrease) in cash and cash equivalents, including restricted cash 39,429 (33,761)Cash and cash equivalents, including restricted cash, at beginning of period 63,025 96,786 Cash and cash equivalents, including restricted cash, at end of period$102,454 $63,025 Supplemental disclosures of cash flow information: Cash paid during the period for interest$211,276 $151,005 Cash paid during the period for income taxes, net of tax refunds received 23,988 44,614 Equipment purchases included in accounts payable 14,288 5,197 Sotera Health CompanyNon-GAAP Financial Measures(in thousands, except per share amounts)(unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019Net loss$(43,386) $(27,746) $(37,491) $(20,425) Amortization20,431 20,005 80,255 80,048 Impairment of long-lived assets and intangible assets (a)— 11 — 5,792 Share-based compensation(b)6,968 1,762 10,987 16,882 Capital restructuring bonuses(c)2,702 1,510 2,702 2,040 (Gain) loss on foreign currency and embedded derivatives(d)(3,663) (5,636) (8,454) 2,662 Acquisition and divestiture related charges, net(e)962 386 3,932 (318) Business optimization project expenses(f)40 2,710 2,524 4,195 Plant closure expenses(g)261 567 2,649 1,712 Loss on extinguishment of debt(h)44,262 30,168 44,262 30,168 Professional services relating to EO sterilization facilities(i)11,301 3,428 36,671 11,216 Accretion of asset retirement obligation(j)470 594 1,946 2,051 COVID-19 expenses(k)314 — 2,677 — Income tax benefit associated with pre-tax adjustments(l)(18,682) (15,270) (43,536) (35,637) Adjusted Net Income21,980 12,489 99,124 100,386 Interest expense, net48,117 43,251 215,259 157,729 Depreciation(m)15,975 16,586 63,309 66,671 Income tax provision applicable to Adjusted Net Income(n)26,990 22,149 42,167 55,146 Adjusted EBITDA$113,062 $94,475 $419,859 $379,932 Net Revenues$216,845 $193,485 $818,158 $778,327 Adjusted EBITDA Margin52.1 % 48.8 % 51.3 % 48.8 %Weighted average number of shares outstanding253,470 232,400 237,696 232,400 Basic and diluted EPS$(0.17) $(0.12) $(0.16) $(0.09) Adjusted EPS$0.09 $0.05 $0.42 $0.43 (a)Represents impairment charges related to the decision to not reopen the Willowbrook, Illinois facility in September 2019.(b)Includes non-cash share-based compensation expense. 2019 also includes $10.0 million of one-time cash share-based compensation expense related to the pre-IPO Class C Units, which vested in the third quarter of 2019.(c)Represents cash bonuses for members of management relating to the November 2020 IPO and the December 2019 refinancing.(d)Represents the effects of (i) fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries’ functional currencies, and (ii) non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion.(e)Represents (i) certain direct and incremental costs related to the acquisitions of Gibraltar Laboratories, Inc. (“Nelson Fairfield”) in 2018 and Iotron Industries Canada, Inc. in July 2020, and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018.(f)Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects.(g)Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.(h)Represents expenses incurred in connection with the refinancing of our debt capital structure in December 2019 and paydown of debt following the November 2020 IPO, including accelerated amortization of prior debt issuance and discount costs, premiums paid in connection with early extinguishment and debt issuance and discount costs incurred for the new debt.(i)Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees.(j)Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.(k)Represents non-recurring costs associated with COVID-19 pandemic, including donations to related charitable causes and special bonuses for front-line personnel working on-site during lockdown periods.(l)Represents the tax benefit or provision associated with the reconciling items between net loss and Adjusted Net Income. To determine the aggregate tax effect of the reconciling items, we utilized statutory income tax rates ranging from 0% to 35%, depending upon the applicable jurisdictions of each adjustment.(m)Includes depreciation of Co-60 held at gamma irradiation sites.(n)Represents the difference between income tax expense or benefit as determined under U.S. GAAP and the income tax benefit associated with pre-tax adjustments described in footnote (l). Sotera Health CompanyNon-GAAP Financial Measures($ in thousands)(unaudited) Year Ended December 31, 2020 2019Current portion of long-term debt$— $16,331 Long-term debt less current portion1,824,789 2,800,873 Current portion of finance leases1,173 1,288 Finance leases less current portion34,939 29,883 Total Debt$1,860,901 $2,848,375 Add: unamortized debt issuance costs and debt discounts38,761 73,677 Less: cash and cash equivalents(102,454) (63,025)Total Net Debt$1,797,208 $2,859,027 Adjusted EBITDA$419,859 $379,932 Net Leverage 4.3x 7.5x
SoFi announced the broad launch of its first-ever credit card, designed to incentivize healthy financial habits and help people get their money right.
Social Finance, Inc. ("SoFi"), the digital personal finance company, today announced that it has signed a definitive agreement to acquire Golden Pacific Bancorp, Inc. (OTCPK: GPBI) and its wholly owned subsidiary Golden Pacific Bank, N.A. (together, "GPB"). GPB is a Sacramento, California-based community bank that is regulated by the Office of the Comptroller of the Currency (OCC) and has approximately $150 million in assets. SoFi will pay $2.55 in cash for each share of GPB or approximately $22.3 million in aggregate to acquire GPB to advance SoFi’s effort to obtain a national bank charter.
MANITOWOC, Wis., March 09, 2021 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting) is a provider of energy-efficient LED lighting, controls and IoT systems, including turnkey project implementation, as well as ongoing system maintenance and program management. Orion announced today that it has received commitments to provide custom LED lighting fixtures for ten additional new facilities of an existing global online retail customer. The ten projects, with anticipated revenue of approximately $7.6 million, will begin in Orion’s fiscal 2021 fourth quarter ending March 31, 2021 and are expected to be completed in Orion’s fiscal 2022 ending March 31, 2022. Orion CEO Mike Altschaefl commented, “Working with a long-term electrical contractor partner to successfully complete past projects placed Orion in an excellent position to build upon the relationship by being selected as their LED lighting supplier for ten additional new facilities. We believe there is an opportunity for this relationship to continue expanding as the customer leverages the illumination, value and energy efficiency benefits of our solutions across their national footprint. “Given Orion’s commitment to industry leading quality, energy-efficiency and customer service, we are especially proud of follow-on orders from existing customers. We view these follow-on orders as a testament to the competitiveness of our custom product design capabilities, our industry-leading quality and energy efficiency, as well as to our commitment to the highest-level of customer service. Orion products also have a reputation for ease of installation with contractors, on top of our commitment to on-time delivery of customized products.” About Orion Energy SystemsOrion provides energy-efficient LED lighting systems and turnkey project implementation including installation and commissioning of fixtures, controls and IoT systems, as well as ongoing system maintenance and program management. We help our customers achieve energy savings with healthy, safe and sustainable solutions, enabling them to reduce their carbon footprint and digitize their business. Safe Harbor Statement Certain matters discussed in this press release, are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements will include words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or words of similar import. Similarly, statements that describe our future plans, objectives or goals, including business relationships with government customers, are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties that could cause results to differ materially from those expected including, but not limited to, the risks described in our filings with the Securities and Exchange Commission. Shareholders, potential investors and other readers are urged to consider risks and uncertainties carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this press release and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov or at http://investor.oriones.com/ in the Investor Relations section of our Website. Except as required by applicable law, we assume no obligation to update any forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future. Twitter: @OrionLighting and @OrionLightingIRStockTwits: @Orion_LED_IR Investor Relations Contacts Per Brodin, CFOWilliam Jones; David CollinsOrion Energy Systems, Inc.Catalyst IRpbrodin@oesx.com(212) 924-9800 or OESX@catalyst-ir.com
22squared creative company focused on social good honored with ranking on Fast Company's Most Innovative Company 2021 list.
Technology stocks have been hammered lately thanks to concerns about their potential overvaluation, but that hasn't affected memory specialist Micron Technology's (NASDAQ: MU) impressive run. Micron's reasonable valuation and its potential to step on the gas in the coming months on the back of favorable memory market dynamics may have kept investors from pushing the sell button, even at a time when some other big names are losing ground on the market. In fact, these are the two reasons why Micron Technology is a stock worth buying right now, as it could keep delivering more upside even if there's a prolonged sell-off in the broader market.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Identity of the person whose positions/dealings are being disclosed:Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Asset Management LP acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree G4S Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:08th March 2021(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: GBP 25p ordinaryISIN: GB00B01FLG62 InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled: (2) Derivatives CFD (other than options): 42,251,2782.7230% (3) Options and agreements to purchase/sell: TOTAL:42,251,2782.7230% All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other executive options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant securityPurchase/sale Number of securitiesPrice per unit (b) Derivatives transactions (other than options) Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitGBPGBP 25p ordinary CFDIncrease a long position54,215242.47GBP 25p ordinary CFDIncrease a long position20,150242.90 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc. Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercising Class of relevant securityProduct descriptione.g. call optionNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached ?NO Date of disclosure:09th March 2021Contact name: Deborah GewinnerTelephone number: +44 203 751 54 12 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk. Attachment 08.03.2021 G4S Plc
Model Intelligence innovator among top-ranked in the Artificial Intelligence category Truera is in the top 10 most innovative companies in Artificial Intelligence Backed by leading venture capital firms Wing, Greylock and Conversion Capital, Truera is already deployed at a number of Fortune 100 customers, including global bank Standard Chartered. REDWOOD CITY, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Truera, which provides the first Model Intelligence platform for AI explainability and model quality, announced today that it has been named to Fast Company’s annual list of the World’s Most Innovative Companies for 2021. Truera is in the top 10 most innovative companies in Artificial Intelligence. “Truera is a company based on deep AI innovation and we are honored to be recognized by Fast Company,” said Anupam Datta, professor of Computer Science at Carnegie Mellon University (CMU) and co-founder, president and chief scientist, Truera. “The pace of evolution in the AI Explainability and Trustworthiness space is extremely rapid, and we are proud to be in the vanguard.” Truera’s model intelligence software removes the “black box” surrounding Machine Learning (ML) to provide intelligence and actionable insights throughout the ML model lifecycle. This enables companies to improve the quality and accuracy of their models, boost stakeholder collaboration, address responsible AI concerns including explainability and bias, and accurately monitor ML models. Truera’s technology builds on six years of AI Explainability research performed at CMU by Datta and Shayak Sen, Truera co-founder and CTO. Building on this research, Truera’s AI explainability technology is a generational improvement over first-generation open source software, driving faster and more accurate AI explanations and analytics. Backed by leading venture capital firms Wing, Greylock and Conversion Capital, Truera is already deployed at a number of Fortune 100 customers, including global bank Standard Chartered. “There is an urgent need for better solutions that ensure AI model quality and trustworthiness during model development and monitoring," said Will Uppington, co-founder and CEO of Truera. “The swift adoption of Truera’s platform among Fortune 100 companies signifies that enterprises are taking this issue seriously, and taking steps to ensure that their AI models are fair and accurate. Truera is the right solution at the right time.” “As AI is increasingly used by industries as diverse as financial services, consumer-facing businesses, manufacturing and governments, a new approach to managing machine learning models across their lifecycle is needed,” said Shayak Sen, Truera co-founder and CTO. “And the big missing piece of this lifecycle management is explaining, debugging and monitoring machine learning models. This is where Truera can be of service.” The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy. “In a year of unprecedented challenges, the companies on this list exhibit fearlessness, ingenuity, and creativity in the face of crisis,” said Fast Company Deputy Editor David Lidsky, who oversaw the issue with Senior Editor Amy Farley. Fast Company’s Most Innovative Companies issue (March/April 2021) is now available online here. To learn more about Truera or schedule a demo, visit https://truera.com/. About Fast CompanyFast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Stephanie Mehta. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com. About Truera Truera provides the first Model Intelligence platform, to help enterprises analyze machine learning, improve and monitor model quality and build trust. Powered by enterprise-class Artificial Intelligence (AI) Explainability technology based on six years of research at Carnegie Mellon University, Truera’s platform helps eliminate the black box surrounding widely used AI and ML technologies. This visibility leads to higher quality, explainable models that sustainably achieve measurable business results, address unfair bias, and ensure governance and compliance. To learn more, visit https://truera.com/. Media contact:Michelle Faulkner617-510-6998michelle@big-swing.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5830493a-83e8-461c-8d49-176ea4ef337e
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 902. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vehicle Scanners Industry" - https://www.reportlinker.com/p06033226/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Vehicle Scanners Market to Reach $2.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Vehicle Scanners estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at aCAGR of 5.1% over the period 2020-2027. Fixed / Static, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Portable / Mobile segment is readjusted to a revised 5.4% CAGR for the next 7-year period. - The U.S. Market is Estimated at $446.3 Million, While China is Forecast to Grow at 7.8% CAGR - The Vehicle Scanners market in the U.S. is estimated at US$446.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$481.1 Million by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR. Select Competitors (Total 42 Featured) - Advanced Detection TechnologyAmba DefenceBharat ElectronicsCass ParkingChemring GroupDahua TechnologyEl-Go TeamGatekeeper SecurityGodrej & BoyceGuardian Industries Read the full report: https://www.reportlinker.com/p06033226/?utm_source=GNW I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Vehicle Scanners Competitor Market Share Scenario Worldwide (in %): 2020E Global Competitor Market Shares by Segment 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Vehicle Scanners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vehicle Scanners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vehicle Scanners by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Fixed / Static by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Fixed / Static by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Fixed / Static by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Portable / Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Portable / Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Portable / Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Drive-through by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Drive-through by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Drive-through by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for UVSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for UVSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for UVSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Government / Critical Infrastructure Protection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Government / Critical Infrastructure Protection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Government / Critical Infrastructure Protection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Private / Commercial Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Private / Commercial Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Private / Commercial Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSISUNITED STATES Market Facts & Figures Market Analytics Table 22: USA Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 23: USA Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: USA 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 25: USA Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 26: USA Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: USA 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 28: USA Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 29: USA Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: USA 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 CANADA Table 31: Canada Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 32: Canada Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: Canada 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 34: Canada Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: Canada Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: Canada 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 37: Canada Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: Canada Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: Canada 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 JAPAN Table 40: Japan Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: Japan Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: Japan 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 43: Japan Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Japan Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Japan 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 46: Japan Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Japan Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Japan 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 CHINA Table 49: China Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: China Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: China 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 52: China Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: China Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: China 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 55: China Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: China Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: China 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures Market Analytics Table 58: Europe Current & Future Analysis for Vehicle Scanners by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 59: Europe Historic Review for Vehicle Scanners by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Europe 15-Year Perspective for Vehicle Scanners by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 61: Europe Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Europe Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Europe 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 64: Europe Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Europe Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Europe 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 67: Europe Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Europe Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Europe 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 FRANCE Table 70: France Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: France Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: France 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 73: France Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: France Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: France 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 76: France Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: France Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: France 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 GERMANY Table 79: Germany Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Germany Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Germany 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 82: Germany Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Germany Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Germany 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 85: Germany Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Germany Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Germany 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 ITALY Table 88: Italy Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Italy Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Italy 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 91: Italy Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Italy Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Italy 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 94: Italy Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Italy Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Italy 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 97: UK Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: UK Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: UK 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 100: UK Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: UK Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: UK 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 103: UK Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: UK Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: UK 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 SPAIN Table 106: Spain Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Spain Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Spain 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 109: Spain Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Spain Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Spain 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 112: Spain Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Spain Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Spain 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 RUSSIA Table 115: Russia Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Russia Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Russia 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 118: Russia Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Russia Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Russia 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 121: Russia Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Russia Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Russia 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 REST OF EUROPE Table 124: Rest of Europe Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Rest of Europe Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Rest of Europe 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales for Fixed / Static and Portable / Mobile for the Years 2012, 2020 & 2027 Table 127: Rest of Europe Current & Future Analysis for Vehicle Scanners by Structure Type - Drive-through and UVSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Rest of Europe Historic Review for Vehicle Scanners by Structure Type - Drive-through and UVSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Rest of Europe 15-Year Perspective for Vehicle Scanners by Structure Type - Percentage Breakdown of Value Sales for Drive-through and UVSS for the Years 2012, 2020 & 2027 Table 130: Rest of Europe Current & Future Analysis for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Rest of Europe Historic Review for Vehicle Scanners by Application - Government / Critical Infrastructure Protection and Private / Commercial Facilities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Rest of Europe 15-Year Perspective for Vehicle Scanners by Application - Percentage Breakdown of Value Sales for Government / Critical Infrastructure Protection and Private / Commercial Facilities for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 133: Asia-Pacific Current & Future Analysis for Vehicle Scanners by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 134: Asia-Pacific Historic Review for Vehicle Scanners by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: Asia-Pacific 15-Year Perspective for Vehicle Scanners by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 Table 136: Asia-Pacific Current & Future Analysis for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: Asia-Pacific Historic Review for Vehicle Scanners by Scanner Type - Fixed / Static and Portable / Mobile Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: Asia-Pacific 15-Year Perspective for Vehicle Scanners by Scanner Type - Percentage Breakdown of Value Sales Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033226/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Surface Computing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 230-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Surface Computing Market to Reach US$147.1 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Surface Computing estimated at US$21.6 Billion in the year 2020, is projected to reach a revised size of US$147.1 Billion by 2027, growing at a CAGR of 31.5% over the period 2020-2027. Flat Display, one of the segments analyzed in the report, is projected to grow at a 28.9% CAGR to reach US$80.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Curved Display segment is readjusted to a revised 35.3% CAGR for the next 7-year period. This segment currently accounts for a 37.3% share of the global Surface Computing market.The U.S. Accounts for Over 30% of Global Market Size in 2020, While China is Forecast to Grow at a 30.7% CAGR for the Period of 2020-2027The Surface Computing market in the U.S. is estimated at US$6.5 Billion in the year 2020. The country currently accounts for a 30.03% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$25.3 Billion in the year 2027 trailing a CAGR of 30.7% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 28.2% and 27.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 22.3% CAGR while Rest of European market (as defined in the study) will reach US$25.3 Billion by the year 2027. Competitors identified in this market include, among others: 3M CompanyApple, Inc.eyefactive GmbHIdeum Inc.Microsoft CorporationNvision Solutions Inc.Planar Systems, Inc.Sensytouch, Inc.Touchmagix Media Private LimitedVertigo Systems GmbH Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Impact of Covid-19 and a Looming Global RecessionGlobal Competitor Market SharesSurface Computing Competitor Market Share Scenario Worldwide (in %): 2018E 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISIV. COMPETITION Total Companies Profiled: 54 For more information about this report visit https://www.researchandmarkets.com/r/75jprg CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Author Kathrin M Allen takes readers on her health journey and provides helpful tools in ‘How I Cured My Chronic Muscle Inflammation. In Just 29 Days!’ “How I Cured My Chronic Muscle Inflammation. In Just 29 Days!” By Kathrin M Allen SYDNEY, March 09, 2021 (GLOBE NEWSWIRE) -- There are so many individuals who suffer chronic muscle inflammation. In Kathrin M Allen’s debut book, “How I Cured My Chronic Muscle Inflammation. In Just 29 Days!” she illustrates how she overcame this suffering by changing her lifestyle for the better. Allen walks readers through her health experiment that ultimately led her to beat inflammation. Readers will be astonished to learn how making simple health choices can turn into extraordinary results.Throughout the guidebook, Allen addresses the years of pain she was living in where she felt like there was no way to find relief. She wanted to find a holistic method to overcome her chronic muscle inflammation and tried everything possible. Readers will be enlightened by Allen’s physical, mental and spiritual discovery that cured her in just 29 days. “I decided to take accountability for my own healing and embarked on a journey over the next 12 months,” said Allen. “My goal was to discover holistic support systems that would enable me to live my best life. My story will show readers that you can cure chronic muscle inflammation by making lifestyle choices that support your body. This way of living with pain does not have to be your ‘normal.’”Allen’s routine will inspire individuals to take the right steps to improve their health beyond what they may think is imaginable. She paints a helpful path for fellow sufferers to a pain-free way of life. By the end of the book, readers will understand what one must do to overcome chronic muscle inflammation and how they can turn their lives around in under 30 days.“How I Cured My Chronic Muscle Inflammation. In Just 29 Days!”By Kathrin M AllenISBN: 978-1-5043-2374-1 (softcover); 978-1-5043-2375-8 (electronic)Available at Balboa Press, Amazon and Barnes & NobleAbout the authorKathrin Allen is thriving in her Bayside Victoria community in Australia. Having journeyed through a 10-year transition state that started with the death of her beloved Mum, Kathrin has survived divorce and two career changes. In 2020 she launched her own business and now wants to share her message with the world, "We all have the power to choose.Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au/ or call 1800 050 315. Attachment Jacket Art CONTACT: Grace Bywater LAVIDGE 480-998-2600 X 534 gbywater@lavidge.com
[175+ Pages Research Report] According to the recent analysis research report; the global Waste To Energy Market in 2019 was approximately USD 17940.4 Million. The market is expected to grow at a CAGR of 7.2% and is anticipated to reach around USD 29187.5 Million by 2026. Top market players are Waste Management Inc., Mitsubishi Heavy Industries Ltd, Suez Environment S.A., Construction Industrielles de la Mediterranee (CNIM) and others.New York, NY, March 09, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Waste To Energy Market By Technology (Thermal and Biological): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026”. “According to the research report, the global Waste To Energy Market was estimated at USD 17940.4 Million in 2019 and is expected to reach USD 29187.5 Million by 2026. The global Waste To Energy Market is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2019 to 2027”. Energy production technologies dedicated to renewable platforms are contributing at a significant level as a replacement for conventional resources. The waste to energy production technologies involved the production of energy from waste material. This energy is considered as pure as well as renewable. The waste to energy production technologies is intended to serve the municipal corporation in reducing the waste as well as the emission from the waste. The energy is recovered in form of electricity or steam. There are primarily two classifications of waste to energy production technologies namely thermal and biological. The thermal energy production technologies involve pyrolysis, gasification, and incineration. Request Your Free Sample Report of Waste To Energy Market @ https://www.fnfresearch.com/sample/waste-to-energy-market-by-technology-thermal-and-1261 (The free sample of this report is readily available on request). Our Free Sample Report Includes: 2020 Updated Report Introduction, Overview, and In-depth industry analysisCOVID-19 Pandemic Outbreak Impact Analysis Included190+ Pages Research Report (Inclusion of Updated Research)Provide Chapter-wise guidance on Request2020 Updated Regional Analysis with Graphical Representation of Size, Share & TrendsIncludes Updated List of table & figuresUpdated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue AnalysisFacts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Questions Answered in this Report 1) What was the impact of COVID-19 on the Waste To Energy Market? 2) What is the market size, share of the Waste To Energy Market? 3) Who are the top market players in the Waste To Energy Market? 4) What will be the future market of the Waste To Energy Market? Key Offerings: Market Size & Forecast by Revenue | 2020−2026Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunitiesMarket Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geographyCompetitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/waste-to-energy-market-by-technology-thermal-and-1261 (You may enquire a report quote OR available discount offers to our sales team before purchase.) Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever. We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients. Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/waste-to-energy-market-by-technology-thermal-and-1261 Waste occupies a significant landmass of usable land. In addition, it also emits toxic elements in the air as well as water bodies, thereby severely affecting environmental elements. Many solutions are been used for the reduction of the environmental impact of waste. One of the important solutions is the production of energy from waste. The production technologies have been evolving with continuous research and development in the field. With the rising concern for waste management, the utilization of waste for the production of energy is gaining increased traction among the municipalities. This inclination towards waste utilization is majorly owing to the rising waste been generated worldwide. The rising waste also poses a potential hazard to the nearby environmental bodies which are additionally catalyzing the demand from the municipalities across the globe. Industry Major Market Companies: Suez Environment S.A.Mitsubishi Heavy Industries LtdC&G Environmental Protection HoldingsConstruction Industrielles de la Mediterranee (CNIM)Waste Management Inc.Babcock & Wilcox Enterprises Inv.A2A SpAVeolia Environnement SAHitachi Zosen CorpChina Everbright International LimitedChina Jinjiang Environment Holding Company Limited To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/waste-to-energy-market-by-technology-thermal-and-1261 Moreover, governments of different countries are supporting and funding environment-sustaining solutions. With major investment in smart city projects, waste recycling and energy production are expected to play a vital role in achieving eco-friendly and sustainable objectives. The thermal technology for waste to energy production is expected to continue its dominance over the period under study. The market dominance is mainly owing to the increasing development and advancements in gasification and incineration technologies. The thermal technology-based WTE is also expected to exhibit the highest growth in the foreseeable future. Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/waste-to-energy-market-by-technology-thermal-and-1261 The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the waste to energy sector. Key strategic developments in the Waste to energy market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the waste to energy market are appropriately highlighted in the report. Rising concern towards waste management and advancement in waste processing and energy harvesting technologies are expected to be the key factor driving the growth of the waste to energy market. Rising waste levels, increasing focus on sustainable urban living, and growing energy demand are further fueling the demand for sustainable environmental solutions. Additionally, governments worldwide are funding environment-saving technologies to reduce the environmental damage caused by the rising level of waste worldwide. Request Customized Copy of Report @ https://www.fnfresearch.com/customization/waste-to-energy-market-by-technology-thermal-and-1261 (We customize your report according to your research need. Ask our sales team for report customization.) The waste to energy market research report delivers an acute valuation and taxonomy of the waste to energy industry by practically splitting the market based on technology and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The waste to energy market is segmented based on technology and region. On the basis of technology segmentation, the market is classified into thermal and biological. Regionally, Europe is expected to lead the global waste to energy market with Germany, France, and Switzerland contributing the highest in the region. The Asia Pacific region is expected to exhibit the highest growth during the forecast period. The demand from major economies in the region such as China, Japan, and India is expected to be the primary growth factor for the Asia Pacific region. Browse the full “Waste To Energy Market By Technology (Thermal and Biological): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” report at https://www.fnfresearch.com/waste-to-energy-market-by-technology-thermal-and-1261 This report segments the global waste to energy market as follow:- Global Waste to energy Market: By Technology Segmentation Analysis ThermalBiological Key Insights from Primary Research Wide-ranging interviews with CXO’s of the major companies operating in the global waste to energy market, the primary research concludes that the global waste to energy market to witness a substantial growth of nearly 7.2 % over the forecast period.In the year 2019, the market was valued at USD 17940.4 million, 2019 and is expected to be valued at over USD 29187.5 million.On the basis of the technology segment, thermal WTE technology dominated the global waste to energy market in 2019. The thermal technology market is also expected to exhibit the highest growth rate over the forecast period.Asia Pacific market is expected to be the fastest-growing region for waste to energy over the forecast period. The primary growth factor in the region is the rising investment in smart city projects and strengthening economies in the region. The European region is expected to dominate the global market in terms of revenue. Related Reports: Aircraft Fuel Tank Market: https://www.fnfresearch.com/aircraft-fuel-tank-market-by-product-type-analysis-1081 Synthetic Ropes Market: https://www.fnfresearch.com/synthetic-ropes-market-synthetic-ropes-market-by-material-1096 White Spirit Market: https://www.fnfresearch.com/white-spirit-market-by-technology-hydrodesulfurization-solvent-extraction-1115 White Marble Market: https://www.marketresearchstore.com/report/global-white-marble-market-report-2019-industry-analysis-675143 Thickness Measuring Devices Market: https://www.marketresearchstore.com/report/global-thickness-measuring-devices-market-report-2018-industry-303235 About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch Follow Us Twitter: https://twitter.com/fnfresearch Contact Us: Facts & Factors USA: +1-347-989-3985 Email: sales@fnfresearch.com Web: https://www.fnfresearch.com Blog: http://fnfnewsblog.com
- Fibrogen veteran brings global R&D expertise to Management Team - - Merck KGaA Executive Sophie (Zhengjie) Sun named Senior Vice President, Corporate Development bringing partnership, strategy and commercialization expertise - FOSTER CITY, Calif. and HANGZHOU, China, March 09, 2021 (GLOBE NEWSWIRE) -- Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of K. Peony Yu, M.D. as Chief Medical Officer. Dr. Yu will assume the role on March 16, 2021. Apollomics also announced that Sophie (Zhengjie) Sun has been named as Senior Vice President, Corporate Development and will be based in the Company’s China office. Both executives report to Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer of the Company. “Dr. Yu joins us with an incredible leadership and global drug development background that is a perfect fit for Apollomics, and we are thrilled to welcome her to our team,” said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. “Peony’s extensive cross border experience includes managing teams in both the U.S. and China and overseeing multiple functions including clinical development, regulatory strategy and medical affairs. Peony will be instrumental in our efforts to advance our current assets and expand our development pipeline.” “Apollomics patient centric focus aligns with my priorities and I am excited to join the team. The Company’s precision medicine approach targeting specific mutations, amplifications and resistance mechanisms is technology that I believe can make a difference and bring transformative therapies to cancer patients. I look forward to contributing to this effort and advancing the clinical development programs globally,” added K. Peony Yu, M.D. Dr. Guo-Liang Yu concluded, “Since inception, Apollomics has built numerous partnerships and we continuously explore options to broaden our portfolio. We are excited to welcome Sophie Sun who will be responsible for corporate strategy, business development, and strategic collaboration. Her diversified career covers three continents and her leadership in strategy, partnering, and commercialization will be a valuable resource as we continue our fight against cancer.” K. Peony Yu, M.D. Dr. Yu spent 12 years at Fibrogen where she served in multiple roles of increasing responsibility culminating in her appointment as Chief Medical Officer in 2016. She brings leadership and expertise in design and execution of clinical development programs in all phases of development, including clinical and regulatory strategy, and interactions with global regulatory authorities. Prior to joining Fibrogen, Dr. Yu was Vice President and Head of Clinical Research at Anesiva, Inc. (formerly known as Corgentech, Inc., (NASDAQ: ANSV)), where she was responsible for management of clinical research, statistics/data management, clinical operations, and medical affairs/medical information for all clinical programs. Dr. Yu received a Doctor of Medicine degree from the University of California, Davis. She completed her residency training at Stanford Medical School. Sophie (Zhengjie) Sun, MBA Sophie Sun joins Apollomics from Merck KGaA, where she was most recently Vice President & Managing Director, Innovation Hubs China. In this role, Ms. Sun oversaw Merck KGaA’s development partnerships in China for China and global markets. She was with Merck KGaA for twelve years holding multiple roles of increasing responsibility including participation in nine new product launches. Prior to Merck KGaA, Ms. Sun spent over eight years at marketing agencies Interpublic Group (IPG) and WPP, where she consulted for many Fortune 500 companies covering a wide range of industries. Ms. Sun received a Master’s degree from Remin University of China, and a Master of Business Administration from MIT Sloan School of Management. About Apollomics, Inc. Apollomics, Inc. is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The company’s existing pipeline consists of several development-stage assets, including novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. For more information, please visit www.apollomicsinc.com. Contact Information: Investor Contact:Wilson W. CheungChief Financial Officer(650) 209-4436wcheung@apollomicsinc.com U.S. Media Contact:Remy BernardaCorporate Communications(415) 203-6386remy.bernarda@apollomicsinc.com China Media Contact:Porda Havas International Finance Communications GroupKelly Fung Phoenix FungGeneral Manager Assistant Vice President(852) 3150 6763 (852) 3150 6773kelly.fung@pordahavas.com phoenix.fung@pordahavas.com
Signify Health, Inc. (NYSE: SGFY) has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, ranking eighth in the Health category. As a fast-growing, mission-oriented company, Signify was recognized for its role in helping to transform the healthcare delivery system so that more people can enjoy healthy, happy days at home.
Georgia’s state Senate narrowly passed a bill that would end no-excuse absentee voting on Monday, as Republicans move to roll back voting access after record turnout led to Democratic victories in the state's presidential US Senate races. (March 9)
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 902. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vehicle Surveillance Industry" - https://www.reportlinker.com/p06033227/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Vehicle Surveillance Market to Reach $157.1 Million by 2027 - Amid the COVID-19 crisis, the global market for Vehicle Surveillance estimated at US$82.3 Million in the year 2020, is projected to reach a revised size of US$157.1 Million by 2027, growing at a CAGR of 9.7% over the analysis period 2020-2027. In-Vehicle, one of the segments analyzed in the report, is projected to record a 9.4% CAGR and reach US$74.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Under-Vehicle segment is readjusted to a revised 9.7% CAGR for the next 7-year period. - The U.S. Market is Estimated at $22.2 Million, While China is Forecast to Grow at 12.8% CAGR - The Vehicle Surveillance market in the U.S. is estimated at US$22.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$33 Million by the year 2027 trailing a CAGR of 12.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 8.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR. - Out Vehicle Segment to Record 10.3% CAGR - In the global Out Vehicle segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$13.6 Million in the year 2020 will reach a projected size of US$25.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$22.5 Million by the year 2027, while Latin America will expand at a 11.7% CAGR through the analysis period. Select Competitors (Total 42 Featured) - Autoliv Inc.Bosch Security System IncorporationComm-Port TechnologiesContinental AGDelphi Automotive PLCDenso CorporationFlir Systems IncorporationHangzhou Hikvision Digital Technology Company LimitedHoneywell Security GroupLaw Enforcement Associates Read the full report: https://www.reportlinker.com/p06033227/?utm_source=GNW I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Vehicle Surveillance Competitor Market Share Scenario Worldwide (in %): 2020E Global Competitor Market Shares by Segment 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Vehicle Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vehicle Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vehicle Surveillance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for In-Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for In-Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for In-Vehicle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Under-Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Under-Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Under-Vehicle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Out Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Out Vehicle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Out Vehicle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSISUNITED STATES Market Facts & Figures Market Analytics Table 13: USA Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 14: USA Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 15: USA 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 CANADA Table 16: Canada Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 17: Canada Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 18: Canada 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 JAPAN Table 19: Japan Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 20: Japan Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 21: Japan 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 CHINA Table 22: China Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 23: China Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 24: China 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures Market Analytics Table 25: Europe Current & Future Analysis for Vehicle Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 26: Europe Historic Review for Vehicle Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 27: Europe 15-Year Perspective for Vehicle Surveillance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 28: Europe Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 29: Europe Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 30: Europe 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 FRANCE Table 31: France Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 32: France Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 33: France 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 GERMANY Table 34: Germany Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 35: Germany Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 36: Germany 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 ITALY Table 37: Italy Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 38: Italy Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 39: Italy 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 40: UK Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 41: UK Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 42: UK 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 SPAIN Table 43: Spain Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 44: Spain Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 45: Spain 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 RUSSIA Table 46: Russia Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 47: Russia Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 48: Russia 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 REST OF EUROPE Table 49: Rest of Europe Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 50: Rest of Europe Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 51: Rest of Europe 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 52: Asia-Pacific Current & Future Analysis for Vehicle Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 53: Asia-Pacific Historic Review for Vehicle Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 54: Asia-Pacific 15-Year Perspective for Vehicle Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 Table 55: Asia-Pacific Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 56: Asia-Pacific Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 57: Asia-Pacific 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 AUSTRALIA Table 58: Australia Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 59: Australia Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 60: Australia 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 INDIA Table 61: India Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 62: India Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 63: India 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 SOUTH KOREA Table 64: South Korea Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 65: South Korea Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 66: South Korea 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 REST OF ASIA-PACIFIC Table 67: Rest of Asia-Pacific Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 68: Rest of Asia-Pacific Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 69: Rest of Asia-Pacific 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 LATIN AMERICA Table 70: Latin America Current & Future Analysis for Vehicle Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 71: Latin America Historic Review for Vehicle Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 72: Latin America 15-Year Perspective for Vehicle Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 Table 73: Latin America Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 74: Latin America Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 75: Latin America 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 ARGENTINA Table 76: Argentina Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 77: Argentina Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 78: Argentina 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 BRAZIL Table 79: Brazil Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 80: Brazil Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 81: Brazil 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 MEXICO Table 82: Mexico Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 83: Mexico Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 84: Mexico 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 REST OF LATIN AMERICA Table 85: Rest of Latin America Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 86: Rest of Latin America Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 87: Rest of Latin America 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 MIDDLE EAST Table 88: Middle East Current & Future Analysis for Vehicle Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR Table 89: Middle East Historic Review for Vehicle Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 90: Middle East 15-Year Perspective for Vehicle Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 Table 91: Middle East Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 92: Middle East Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 93: Middle East 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 IRAN Table 94: Iran Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 95: Iran Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 96: Iran 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 ISRAEL Table 97: Israel Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 98: Israel Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 99: Israel 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 SAUDI ARABIA Table 100: Saudi Arabia Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 101: Saudi Arabia Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 102: Saudi Arabia 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 UNITED ARAB EMIRATES Table 103: UAE Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 104: UAE Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 105: UAE 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 REST OF MIDDLE EAST Table 106: Rest of Middle East Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 107: Rest of Middle East Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 108: Rest of Middle East 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 AFRICA Table 109: Africa Current & Future Analysis for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR Table 110: Africa Historic Review for Vehicle Surveillance by Type - In-Vehicle, Under-Vehicle and Out Vehicle Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR Table 111: Africa 15-Year Perspective for Vehicle Surveillance by Type - Percentage Breakdown of Value Sales for In-Vehicle, Under-Vehicle and Out Vehicle for the Years 2012, 2020 & 2027 IV. COMPETITIONTotal Companies Profiled: 42Read the full report: https://www.reportlinker.com/p06033227/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
There are now 15 states (plus Washington, D.C.) that have legalized recreational marijuana, creating a wild west of opportunities for large dispensary chains and individual growers alike. GW Pharmaceuticals markets Epidiolex, a cannabinoid drug that can reduce the occurrence of seizures in patients with epilepsy by about 50%.